E. Denamur et al., WT1 splice-site mutations are rarely associated with primary steroid-resistant focal and segmental glomerulosclerosis, KIDNEY INT, 57(5), 2000, pp. 1868-1872
Background Donor splice-site de novo heterozygous mutations in intron 9 of
the Wilms' tumor gene (WT1) have been reported in Frasier syndrome, which i
s defined by the association of focal and segmental glomerulosclerosis (FSG
S), male pseudohermaphroditism, and gonadoblastoma. These splice-site mutat
ions alter the WT1 alternative splicing leading to two WT1 isoforms, with (
+) or without (-) three amino acids, lysine-threonine-serine (KTS), between
zinc fingers 3 and 4. The aim of this work was to investigate the possibil
ity that some cases of primary steroid-resistant nephrotic syndrome associa
ted with FSGS may be caused by WT1 splice-site mutations.
Methods. We analyzed WT1 exons 8 and 9 and the surrounding exon/intron boun
dary DNA sequences in 37 children with nonfamilial primary steroid-resistan
t nephrotic syndrome. Semiquantitative reverse transcription-polymerase cha
in reaction (RT-PCR) was used to determine the relative ratio of +KTS/-KTS
transcripts from immortalized lymphocyte RNA.
Results. One boy with FSGS and associated pathologies (diaphragmatic hernia
, proximal hypospadias, and unilateral testicular ectopia) was found to car
ry the heterozygous 1228 +4 C-->T splice-site mutation. RT-PCR quantitation
of the +KTS/ -KTS transcripts from immortalized lymphocyte RNA of this pat
ient showed a diminution of the +KTS/-KTS isoform ratio (0.43), which is id
entical to that reported in patients with Frasier syndrome. Using the same
approach, healthy control subjects have +KTS/-KTS ratios ranging from 1.50
to 2.00.
Conclusions. This study expands the range of the phenotypic presentation of
the intron 9 splice-site WT1 mutations and adds to the already reported he
terogeneity of primary steroid-resistant nephrotic syndromes. We suggest th
at these mutations are not likely to be a common cause of isolated steroid-
resistant nephrotic syndrome, and recommend a WT1 exon 9/intron 9 splice-si
te study in children with primary steroid-resistant nephrotic syndrome if g
enital or diaphragmatic anomalies are associated. The identification of suc
h WT1 mutations has practical implications for the management of these pati
ents.